List of Tables
Table 1: Pain Therapeutics Market, Global, Approved Indications for Celebrex, 2017 23
Table 2: Pain Therapeutics Market, Global, Approved Indications for Nucynta, 2017 24
Table 3: Pain Therapeutics Market, Global, Approved Indications for Lyrica, 2017 26
Table 4: Pain Therapeutics Market, Global, Approved Indications for Exparel, 2017 27
Table 5: Pain Therapeutics Market, Global, Approved Indications for Voltaren, 2017 28
Table 6: Pain Therapeutics Market, Global, Approved Indications for Pennsaid, 2017 29
Table 7: Pain Therapeutics Market, Global, Approved Indications for Depakine, 2017 30
Table 8: Pain Therapeutics Market, Global, Approved Indications for Embeda ER, 2017 31
Table 9: Pain Therapeutics Market, Global, Approved Indications for Cymbalta, 2017 33
Table 10: Pain Therapeutics Market, Global, Usage of Generics Across Key Indications, 2016 68
Table 11: Pain Therapeutics Market, Global, Forecast Revenues by Company, 2016–2023 82
Table 12: Pain Therapeutics Market, Global, Pipeline Products, Discovery, 2017 110
Table 13: Pain Therapeutics Market, Global, Pipeline Products, Preclinical, 2017 115
Table 14: Pain Therapeutics Market, Global, Pipeline Products, IND/CTA-filed, 2017 131
Table 15: Pain Therapeutics Market, Global, Pipeline Products, Phase I, 2017 131
Table 16: Pain Therapeutics Market, Global, Pipeline Products, Phase II, 2017 135
Table 17: Pain Therapeutics Market 138
Table 18: Pain Therapeutics Market, Global, Pipeline Products, Pre-registration, 2017 141
Table 19: Pain Therapeutics Market, Global, Pipeline Products, Unknown, 2017 141
Table 20: Pain therapeutics Market, Epidemiology Patterns for Migraine, 2016–2023 142
Table 21: Pain therapeutics Market, Epidemiology Patterns for Post-Herpetic Neuralgia, 2016–2023 143
Table 22: Pain therapeutics Market, Epidemiology Patterns for Trigeminal Neuralgia, 2016–2023 143
Table 23: Abbreviations 144